Literature DB >> 1664112

Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists.

G A Higgins1, B J Jones, N R Oakley, M B Tyers.   

Abstract

The effects of various 5-HT3 receptor antagonists were examined in the social interaction (SI) test following discrete microinjection into either the dorsal raphe nucleus (DRN) or amygdala of the rat. Following DRN injection, ondansetron, ICS205-930, and MDL72222 (5-500 ng) all failed to modify SI under high light/unfamiliar (HLU) test conditions relative to vehicle pretreated controls. The 5-HT3 receptor agonist, 2-Me 5-HT (100-2500 ng), was similarly ineffective under both HLU and low light/familiar (LLF) conditions, although 5-HT (20-100 ng) increased SI under the HLU paradigm. After amygdaloid injection, ondansetron (10-100 ng), granisetron (1-10 ng), ICS205-930 (10-100 ng), GR 65630 (1-10 ng), and MDL72222 (100-1000 ng) all significantly increased SI under the HLU but not LLF condition. Furthermore, a detailed behavioural analysis revealed that the behaviours underlying this increase were similar to those seen in vehicle pretreated animals tested in the LLF compared to HLU condition. The benzodiazepine, flurazepam (200 ng), increased both SI (HLU condition) and punished responding in a modified water-lick conflict model, after amygdaloid injection. Both ondansetron (10-1000 ng) and ICS205-930 (1-100 ng) were ineffective in the conflict test. Finally, 2-Me 5-HT and 5-HT (100-10,000 ng) reduced SI under the LLF test condition with no concomitant change in locomotor activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664112     DOI: 10.1007/bf02245664

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Behavioural effects in gerbils of the 5-HT3 receptor antagonists, BRL 43694 and ICS 205-930, under circumstances of high and low light intensity.

Authors:  M G Cutler
Journal:  Neuropharmacology       Date:  1990-06       Impact factor: 5.250

2.  Correlation of [3H]diazepam binding density with anxiolytic locus in the amygdaloid complex of the rat.

Authors:  S R Thomas; M E Lewis; S D Iversen
Journal:  Brain Res       Date:  1985-09-02       Impact factor: 3.252

3.  Anti-anxiety action of diazepam after intra-amygdaloid application in the rat.

Authors:  J Nagy; K Zámbó; L Decsi
Journal:  Neuropharmacology       Date:  1979-06       Impact factor: 5.250

4.  Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice.

Authors:  T Kilfoil; A Michel; D Montgomery; R L Whiting
Journal:  Neuropharmacology       Date:  1989-09       Impact factor: 5.250

5.  Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.

Authors:  A Butler; J M Hill; S J Ireland; C C Jordan; M B Tyers
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

6.  Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.

Authors:  G J Kilpatrick; B J Jones; M B Tyers
Journal:  Nature       Date:  1987 Dec 24-31       Impact factor: 49.962

7.  Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species.

Authors:  G J Kilpatrick; B J Jones; M B Tyers
Journal:  Eur J Pharmacol       Date:  1989-01-10       Impact factor: 4.432

8.  5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret.

Authors:  G A Higgins; G J Kilpatrick; K T Bunce; B J Jones; M B Tyers
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

9.  Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve.

Authors:  S J Ireland; M B Tyers
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

10.  Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse.

Authors:  B Costall; M E Kelly; R J Naylor; E S Onaivi; M B Tyers
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

View more
  18 in total

1.  Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection.

Authors:  G A Higgins; B J Jones; N R Oakley
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Effect of the 5-HT3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning.

Authors:  G A Higgins; N Joharchi; P Nguyen; E M Sellers
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  A novel subpopulation of 5-HT type 3A receptor subunit immunoreactive interneurons in the rat basolateral amygdala.

Authors:  F Mascagni; A J McDonald
Journal:  Neuroscience       Date:  2006-12-05       Impact factor: 3.590

4.  Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat.

Authors:  Brittney M Cox; Mrudang M Shah; Teri Cichon; Manuel E Tancer; Matthew P Galloway; David M Thomas; Shane A Perrine
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-10-10       Impact factor: 5.067

5.  Adolescent anabolic/androgenic steroids: Aggression and anxiety during exposure predict behavioral responding during withdrawal in Syrian hamsters (Mesocricetus auratus).

Authors:  Lesley A Ricci; Thomas R Morrison; Richard H Melloni
Journal:  Horm Behav       Date:  2013-10-11       Impact factor: 3.587

Review 6.  The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors:  A J Greenshaw; P H Silverstone
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 7.  Sleep disturbances: one of the culprits of obesity-related cardiovascular risk?

Authors:  Giovanna Muscogiuri; Dario Tuccinardi; Vincenzo Nicastro; Luigi Barrea; Annamaria Colao; Silvia Savastano
Journal:  Int J Obes Suppl       Date:  2020-07-20

8.  Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety.

Authors:  G A Kennett; F Bailey; D C Piper; T P Blackburn
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

Review 9.  5HT drugs in animal models of anxiety.

Authors:  S L Handley; J W McBlane
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties.

Authors:  G A Kennett; M D Wood; F Bright; J Cilia; D C Piper; T Gager; D Thomas; G S Baxter; I T Forbes; P Ham; T P Blackburn
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.